Similarly, exosomes derived from engineered Jurkat T cells expressing IL-2 on their surface were shown to reprogram miRNA levels, suppress PD-L1 expression in melanoma cells, and inhibit tumor growth in immunocompetent mouse models (Jung et al. 2022). The gene discussed is IL2; the disease is melanoma.